CALCIMAR 200 UNIT — DIN 01926691
CALCITONIN (SALMON SYNTHETIC) : 200 UNIT · SANOFI-AVENTIS CANADA INC · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is CALCIMAR?
CALCIMAR 200 UNIT contains CALCITONIN (SALMON SYNTHETIC) : 200 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01926691, held by SANOFI-AVENTIS CANADA INC, supplied as SOLUTION for SUBCUTANEOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 13-Feb-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CALCIMAR used for?
Symptomatic Paget's disease (refractory to other treatments) and early treatment of hypercalcemic emergencies.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Calcitonin (Salmon Synthetic) in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Calcitonin (Salmon Synthetic), across 10 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SANOFI-AVENTIS CANADA INC | 1 | 1 | CALCIMAR | Sourceable in Canada |
| APOTEX INC | 2 | 0 | APO-CALCITONIN INJECTABLE, APO-CALCITONIN NASAL SPRAY | No marketed DIN |
| FERRING INC | 2 | 0 | CALTINE INJ 100 UNIT/ML (1ML AMP), CALTINE INJ 100UNIT/ML (0.5ML AMP) | No marketed DIN |
| NOVARTIS PHARMACEUTICALS CANADA INC | 2 | 0 | MIACALCIN INJECTION 200IU/ML, MIACALCIN NASAL SPRAY 200 IU | No marketed DIN |
| PRO DOC LIMITEE | 1 | 0 | PRO-CALCITONIN - 200 | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 1 | 0 | SANDOZ-CALCITONIN NS | No marketed DIN |
| STERIMAX INC | 1 | 0 | CALCITONIN SALMON INJECTION USP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 UNIT |
|---|---|
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS ; INTRAMUSCULAR |
| Pack configuration (monograph) | 400 International Units per 2 mL multidose vial. |
| Storage | Store at refrigerator temperature (2-8°C). Stable for 2 weeks at controlled room temperature (15-30°C). |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Substance and classification
| Active substance | Calcitonin (Salmon Synthetic) |
|---|---|
| ATC code | H05BA01 |
| AHFS class | 68:24.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01926691 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1926691 |
| Brand name | CALCIMAR |
| Generic / active ingredient | CALCITONIN (SALMON SYNTHETIC) : 200 UNIT |
| Market authorization holder | SANOFI-AVENTIS CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | H05BA01 |
| ATC anatomical main group | H — Systemic hormonal preparations |
| ATC therapeutic subgroup | H05BA |
| Current status | MARKETED |
| Status date | 13-Feb-2008 |
| Original market date | 1983-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Paget's: 100 IU/day SC/IM (min 50 IU 3x/week). Hypercalcemia: 4 IU/kg every 12h SC/IM, may increase to 8 IU/kg every 6-12h. Use shortest duration possible.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to CALCIMAR or to any ingredient in the formulation or component of the container.
Warnings and precautions
Increased risk of malignancies with long-term use. Potential for serious allergic-type reactions/anaphylaxis. Risk of hypocalcemic tetany. Limit treatment duration.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CALCITONIN INJECTABLE | 200 UNIT | LIQUID | APOTEX INC | CANCELLED POST MARKET | 02246058 |
| APO-CALCITONIN NASAL SPRAY | 200 UNIT | SOLUTION | APOTEX INC | CANCELLED POST MARKET | 02247585 |
| CALCITONIN SALMON INJECTION USP | 200 UNIT | SOLUTION | STERIMAX INC | APPROVED | 02383233 |
| CALTINE INJ 100 UNIT/ML (1ML AMP) | 100 UNIT | LIQUID | FERRING INC | CANCELLED POST MARKET | 02007134 |
| CALTINE INJ 100UNIT/ML (0.5ML AMP) | 100 UNIT | LIQUID | FERRING INC | CANCELLED POST MARKET | 01940376 |
| MIACALCIN INJECTION 200IU/ML | 200 UNIT | LIQUID | NOVARTIS PHARMACEUTICALS CANADA INC | APPROVED | 02144301 |
| MIACALCIN NASAL SPRAY 200 IU | 200 UNIT | SPRAY | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | 02240775 |
| PRO-CALCITONIN - 200 | 200 UNIT | SOLUTION | PRO DOC LIMITEE | CANCELLED POST MARKET | 02311046 |
| SANDOZ-CALCITONIN NS | 200 UNIT | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | 02261766 |
2 · Same class — other molecules in ATC H05BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Calcitonin (Salmon Synthetic) | APO-CALCITONIN INJECTABLE · APO-CALCITONIN NASAL SPRAY · CALCIMAR · CALCITONIN SALMON INJECTION USP · +6 more | 10 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC H05B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| H05BX | Cinacalcet · Doxercalciferol · Paricalcitol | 47 | 22 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.